Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, Inc. is a publicly traded, specialty pharmaceutical company that focuses on the development, manufacture, and marketing of generic and proprietary injectable, inhalation, and intranasal products. The company is headquartered in Rancho Cucamonga, California.
History[edit | edit source]
Amphastar Pharmaceuticals was founded in 1996. The company has grown through a combination of internal development and strategic acquisitions. Over the years, Amphastar has expanded its product portfolio and manufacturing capabilities, establishing itself as a significant player in the pharmaceutical industry.
Products[edit | edit source]
Amphastar Pharmaceuticals offers a range of products, including:
Some of the notable products include:
- Epinephrine injection
- Naloxone injection
- Enoxaparin sodium injection
Research and Development[edit | edit source]
The company invests significantly in research and development (R&D) to bring new and innovative products to market. Amphastar's R&D efforts are focused on developing generic versions of existing drugs as well as proprietary products that address unmet medical needs.
Manufacturing[edit | edit source]
Amphastar Pharmaceuticals operates multiple manufacturing facilities in the United States and China. These facilities are equipped with advanced technology and comply with stringent regulatory standards to ensure the quality and safety of their products.
Regulatory Compliance[edit | edit source]
Amphastar Pharmaceuticals adheres to the regulations set forth by the U.S. Food and Drug Administration (FDA) and other international regulatory bodies. The company is committed to maintaining high standards of quality and safety in all aspects of its operations.
Financial Performance[edit | edit source]
As a publicly traded company, Amphastar Pharmaceuticals is listed on the NASDAQ under the ticker symbol AMPH. The company regularly reports its financial performance, including revenue, net income, and other key financial metrics.
See Also[edit | edit source]
Related Pages[edit | edit source]
| Amphastar Pharmaceuticals Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
